Recurrent and founder mutations in the Netherlands—Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy

Documenti analoghi

• The phospholamban p.Arg14del founder mutation in Dutch patients with arrhythmogenic cardiomyopathy
  di: van der Heijden, J. F., et al.
  Pubblicazione: (2013)
• Recurrent and founder mutations in the Netherlands: Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasia
  di: van der Zwaag, P.A., et al.
  Pubblicazione: (2011)
• Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers–reaching the frontiers of individual risk prediction
  di: Verstraelen, Tom E, et al.
  Pubblicazione: (2021)
• Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy
  di: van der Zwaag, Paul A., et al.
  Pubblicazione: (2012)
• Prevalence and cardiac phenotype of patients with a phospholamban mutation
  di: Hof, I. E., et al.
  Pubblicazione: (2018)